KPC Pharmaceuticals Inc (600422) — Cash Flow-to-Debt Ratio
KPC Pharmaceuticals Inc (600422) has a Cash Flow-to-Debt Ratio of 0.00x as of September 2025, meaning its operating cash flow of CN¥-16.66 Million could theoretically repay 0% of its total liabilities (CN¥5.15 Billion) in one year. See cash generation quality of KPC Pharmaceuticals Inc to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
KPC Pharmaceuticals Inc Cash Flow-to-Debt Ratio (1999–2024)
Historical debt coverage capacity for KPC Pharmaceuticals Inc across 26 annual periods. Also explore 600422 net assets growth trend to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for KPC Pharmaceuticals Inc (1999–2024)
Year-by-year debt coverage analysis for KPC Pharmaceuticals Inc. For market capitalisation and broader financial context, see 600422 market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.14x | CN¥808.07 Million | CN¥5.87 Billion | ▲ +58.2% |
| 2023 | 0.09x | CN¥356.08 Million | CN¥4.09 Billion | ▲ +47.1% |
| 2022 | 0.06x | CN¥253.90 Million | CN¥4.29 Billion | ▼ -7.0% |
| 2021 | 0.06x | CN¥251.63 Million | CN¥3.95 Billion | ▼ -45.3% |
| 2020 | 0.12x | CN¥409.94 Million | CN¥3.52 Billion | ▼ -15.9% |
| 2019 | 0.14x | CN¥429.50 Million | CN¥3.10 Billion | ▲ +15.8% |
| 2018 | 0.12x | CN¥352.07 Million | CN¥2.94 Billion | ▲ +26.5% |
| 2017 | 0.09x | CN¥242.53 Million | CN¥2.56 Billion | ▼ -45.6% |
| 2016 | 0.17x | CN¥311.16 Million | CN¥1.79 Billion | ▼ -41.2% |
| 2015 | 0.30x | CN¥476.62 Million | CN¥1.61 Billion | ▼ -24.0% |
| 2014 | 0.39x | CN¥379.13 Million | CN¥974.40 Million | ▲ +61.9% |
| 2013 | 0.24x | CN¥241.97 Million | CN¥1.01 Billion | ▲ +23.4% |
| 2012 | 0.19x | CN¥213.33 Million | CN¥1.10 Billion | ▼ -1.0% |
| 2011 | 0.20x | CN¥140.24 Million | CN¥712.37 Million | ▲ +29.2% |
| 2010 | 0.15x | CN¥90.82 Million | CN¥595.84 Million | ▼ -40.0% |
| 2009 | 0.25x | CN¥128.57 Million | CN¥505.79 Million | ▲ +35.0% |
| 2008 | 0.19x | CN¥91.59 Million | CN¥486.48 Million | ▼ -19.7% |
| 2007 | 0.23x | CN¥130.06 Million | CN¥554.98 Million | ▲ +108.3% |
| 2006 | 0.11x | CN¥61.25 Million | CN¥544.44 Million | ▲ +141.9% |
| 2005 | -0.27x | CN¥-174.52 Million | CN¥650.31 Million | ▼ -4235.1% |
| 2004 | -0.01x | CN¥-2.78 Million | CN¥448.75 Million | ▼ -102.9% |
| 2003 | 0.21x | CN¥61.23 Million | CN¥286.76 Million | ▲ +136.0% |
| 2002 | 0.09x | CN¥17.38 Million | CN¥192.11 Million | ▼ -72.4% |
| 2001 | 0.33x | CN¥67.07 Million | CN¥204.24 Million | ▲ +65.8% |
| 2000 | 0.20x | CN¥47.76 Million | CN¥241.15 Million | ▼ -3.3% |
| 1999 | 0.20x | CN¥60.24 Million | CN¥294.19 Million | — |